Michael VanSaun

8PUBLICATIONS
11CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 14, 2025
Combined Omipalisib and MAPK Inhibition Suppress PDAC Growth.

Bailey A Bye, Jarrid L Jack, Alexandra Pierce

|Mar 22, 2025
Depletion of tumor-derived CXCL5 improves T cell infiltration and anti-PD-1 therapy response in an obese model of pancreatic cancer.

Richard McKinnon Walsh, Joseph Ambrose, Jarrid L Jack

|Jun 21, 2024
CREB drives acinar cells to ductal reprogramming and promotes pancreatic cancer progression in preclinical models of alcoholic pancreatitis.

Supriya Srinivasan, Siddharth Mehra, Sudhakar Jinka

|Aug 30, 2023
Combined PI3K and MAPK inhibition synergizes to suppress PDAC.

Bailey A Bye, Jarrid Jack, Alexandra Pierce

|Aug 30, 2023
Adipose-Tumor Crosstalk contributes to CXCL5 Mediated Immune Evasion in PDAC.

R McKinnon Walsh, Joseph Ambrose, Jarrid L Jack

|Sep 08, 2022
SHP2 regulates adipose maintenance and adipocyte-pancreatic cancer cell crosstalk via PDHA1.

Appolinaire A Olou, Joe Ambrose, Jarrid L Jack

Pageof 2